IRIS
SANTINI, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 234
EU - Europa 139
AS - Asia 81
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 228
IE - Irlanda 103
CN - Cina 80
FI - Finlandia 21
DE - Germania 8
CA - Canada 6
IT - Italia 3
AU - Australia 2
BE - Belgio 2
AR - Argentina 1
IN - India 1
MU - Mauritius 1
SE - Svezia 1
UA - Ucraina 1
Totale 458
Salva come PNG Salva come JPEG
Città #
Dublin 103
Chandler 74
Beijing 43
Ashburn 23
Helsinki 21
Shanghai 16
Lawrence 15
Medford 15
Princeton 15
Wilmington 9
Nanjing 7
Toronto 6
Ann Arbor 5
Nanchang 4
Fairfield 3
Jiaxing 3
Brussels 2
Canberra 2
Changsha 2
New York 2
Norwalk 2
Shenyang 2
Cambridge 1
Dearborn 1
Fremont 1
Hebei 1
Pavia 1
Pognana Lario 1
Pune 1
Tianjin 1
Torino 1
Washington 1
Woodbridge 1
Totale 385
Salva come PNG Salva come JPEG
Nome #
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? 43
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 40
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 34
Natural history of malignant bone disease in gastric cancer; final results of a multicenter bone metastatis survey 34
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 34
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 33
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis 32
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 32
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 30
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 30
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises 29
Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma 27
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 27
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 26
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 25
Totale 476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 1 0 0
2019/202077 7 11 0 0 0 0 13 3 0 24 19 0
2020/202110 0 0 0 0 0 2 0 7 0 0 1 0
2021/202267 0 1 7 0 1 0 0 5 1 1 14 37
2022/2023237 31 27 3 8 15 18 0 11 115 2 3 4
2023/202481 19 16 3 2 4 20 13 1 2 1 0 0
Totale 476